SecBot SecBot
144 ·Filed Oct 2, 2026

SRTA

Strata Critical Medical, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed25d 1h ago SEC0001969223-26-001051
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

The filing is a routine intent-to-sell by a former board member; the shares were acquired in a merger over a year ago. No immediate catalyst is indicated. Monitor for actual Form 4 filings to confirm execution, and watch for any additional insider selling patterns that could signal broader sentiment.

DirectionNeutral
Confidencemedium
Horizondays
Latest settled — T+5d
SRTA ▼ -4.23% at T+5d
NEUTRAL call -4.23% · α vs SPY -5.39% · entry $4.73 → $4.53
Next anchor: T+20d in 3d
Latest observation: T+15 +5.78% FF3 residual α
Entry = T+0 close
Oct 2, 2026
via day close
T+1d
+1.69%
call +1.69% · α +1.02%
$4.81
settled 22d ago
T+5d
-4.23%
call -4.23% · α -5.39%
$4.53
settled 18d ago
T+20d
Pending
in 3d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

Former board member Eric Affeldt, through his living trust, filed a Form 144 to sell 100,000 Class A shares of Strata Critical Medical (SRTA), with an estimated aggregate market value of $517,000 based on a reported price of approximately $5.17 per share. The shares were acquired in a merger with Blade Air Mobility in August 2025, and the filing signals intent to sell control securities in the near term.

Key Facts

  • Filer: The Eric L. Affeldt Living Trust (Eric Affeldt, former board member, trustee)
  • Shares to be sold: 100,000 shares of Class A common stock
  • Estimated aggregate market value: $517,000 (approx. $5.17/share)
  • Shares acquired on 08/29/2025 via merger with Blade Air Mobility, Inc.
  • Filing date: 10/02/2026
  • Broker: UBS Financial Services Inc.

Financial Impact

Proposed sale of $517,000 in shares — approximately 0.58% of the company's market cap based on the filing's estimated value and the company's market cap of ~$88.5M (100,000 shares × $5.17 / 0.58% implies ~$88.5M cap).

dilutioninsider selling

Risk Factors

  • Insider selling may be perceived as lack of confidence, though the seller is a former board member, not current management
  • The sale may not be executed — Form 144 is only an intent to sell

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001969223-26-001051
Document: 0001969223-26-001051-index.html0001969223-26-001051
Document: 0001969223-26-001051.txt0001969223-26-001051
10 reports for SRTA
Performance horizon
67% Hit rate @ T+1 4 of 6 directional calls Went positive at some point 5 of 6 best @ T+60▲ +36.75%Feb 28, 2026
Filters
Rows
Reports for SRTA — sortable, filterable
TypeNow
Oct 23, 2026
3d ago
Press Release
NEUTRAL ★ 1/10
$4.66awaiting T+1—$4.76 (+2.15%)
Oct 15, 2026
11d ago
SC 13D
BULLISH ★ 7/10
$4.54 $4.54· 0.00%▼ −0.42%$4.76 (+4.85%)
Oct 2, 2026
25d ago
144
NEUTRAL ★ 3/10
$4.73 $4.81▲ +1.69%▲ +1.02%$4.76 (+0.63%)
Aug 21, 2026
9w ago
Institutional Cluster
BULLISH ★ 5/10
$6.24 $5.97▼ −4.33%▼ −4.03%$4.76 (−23.72%)
Aug 4, 2026
12w ago
8-K
BULLISH ★ 7/10
$5.57 $5.85▲ +5.03%▲ +5.23%$4.76 (−14.54%)
Jul 21, 2026
13w ago
Press Release
NEUTRAL ★ 1/10
$5.08 $5.09▲ +0.20%▲ +1.43%$4.76 (−6.30%)
Jun 10, 2026
19w ago
Insider Cluster
BEARISH ★ 4/10
$5.49 $5.43▲ +1.09%▲ +1.63%$4.76 (+13.30%)
May 7, 2026
24w ago
Press Release
NEUTRAL ★ 2/10
$5.57 $5.66▲ +1.62%▲ +1.38%$4.76 (−14.54%)
Mar 3, 2026
34w ago
Press Release
BULLISH ★ 8/10
$4.80 $4.89▲ +1.88%▲ +1.11%$4.76 (−0.83%)
Feb 28, 2026
34w ago
Institutional Cluster
BULLISH ★ 6/10
$4.49 $4.80▲ +6.90%▲ +7.82%$4.76 (+6.01%)
Showing 10 of 10

US Market Status

Market Open — Closes in 1h 44m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 2, 2026